Portability Meets Precision
Our Compact Fieldable Reader brings diagnostics to the field. Uncover the transformative impact of this portable technology.
Our Compact Fieldable Reader brings diagnostics to the field. Uncover the transformative impact of this portable technology.
Aviana's detection technology will be rapid and correct, alleviating the need for multiple laboratory based testing , supporting patients and healthcare professionals in swift and accurate diagnosis. Our platform seamlessly integrates into existing workflows.
Found here is information regarding Real-time Sensing System empowering swift and accurate disease detection. Dive into our breakthrough technology reshaping healthcare diagnostics, further information can be found in the publication section.
Aviana’s technology has been shown to determine in a single test the presence of Lyme disease and can supplement two expensive and time consuming tests. Aviana’s test can determine the presence of acute active disease and previous infections, making it versatile. This can be determined by any health care professional in any setting since no sample preparation is needed, only a few drops of blood. This data has been presented at a CDC conference on Lyme Disease.
From funding obtained from the US Air Force, Aviana’s technology can determine the presence of an acute COVID infection and the presence of previous infection and vaccination. This can be done accurately and rapidly in any setting without the need for any laboratory processes and the data sent to both the medical records and to public health agencies as needed. This assay is quantitative and accurate. This data has been presented at a conference on Military based research.